An 'Obvious' Ruling In Abilify Composition Patent Case

In an opinion that referred to a defendant's obviousness case for a small-molecule drug as "a poster child for impermissible hindsight reasoning," the U.S. Court of Appeals for the Federal Circuit...

Already a subscriber? Click here to view full article